Literature DB >> 19171194

Truncated dystrophins can influence neuromuscular synapse structure.

Glen B Banks1, Jeffrey S Chamberlain, Stanley C Froehner.   

Abstract

Duchenne muscular dystrophy (DMD) is characterized by muscle degeneration and structural defects in the neuromuscular synapse that are caused by mutations in dystrophin. Whether aberrant neuromuscular synapse structure is an indirect consequence of muscle degeneration or a direct result of loss of dystrophin function is not known. Rational design of truncated dystrophins has enabled the design of expression cassettes highly effective at preventing muscle degeneration in mouse models of DMD using gene therapy. Here we examined the functional capacity of a minidystrophin (minidysGFP) and a microdystrophin (microdystrophin(DeltaR4-R23)) transgene on the maturation and maintenance of neuromuscular junctions (NMJ) in mdx mice. We found that minidysGFP prevents fragmentation and the loss of postsynaptic folds at the NMJ. In contrast, microdystrophin (DeltaR4-R23) was unable to prevent synapse fragmentation in the limb muscles despite preventing muscle degeneration, although fragmentation was observed to temporally correlate with the formation of ringed fibers. Surprisingly, microdystrophin(DeltaR4-R23) increased the length of synaptic folds in the diaphragm muscles of mdx mice independent of muscle degeneration or the formation of ringed fibers. We also demonstrate that the number and depth of synaptic folds influences the density of voltage-gated sodium channels at the neuromuscular synapse in mdx, microdystrophin(DeltaR4-R23)/mdx and mdx:utrophin double knockout mice. Together, these data suggest that maintenance of the neuromuscular synapse is governed through its lateral association with the muscle cytoskeleton, and that dystrophin has a direct role in promoting the maturation of synaptic folds to allow more sodium channels into the junction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171194      PMCID: PMC2826111          DOI: 10.1016/j.mcn.2008.12.011

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  48 in total

Review 1.  Development of the vertebrate neuromuscular junction.

Authors:  J R Sanes; J W Lichtman
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

Review 2.  The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors:  S J Winder
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 2.698

3.  The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles.

Authors:  S J Wood; C R Slater
Journal:  J Physiol       Date:  1997-04-01       Impact factor: 5.182

Review 4.  The spectrin-based membrane skeleton and micron-scale organization of the plasma membrane.

Authors:  V Bennett; D M Gilligan
Journal:  Annu Rev Cell Biol       Date:  1993

5.  Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.

Authors:  R M Grady; H Teng; M C Nichol; J C Cunningham; R S Wilkinson; J R Sanes
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice.

Authors:  A E Deconinck; A C Potter; J M Tinsley; S J Wood; R Vater; C Young; L Metzinger; A Vincent; C R Slater; K E Davies
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

7.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

8.  Localization of dystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle.

Authors:  R Sealock; M H Butler; N R Kramarcy; K X Gao; A A Murnane; K Douville; S C Froehner
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

9.  Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.

Authors:  A A Hack; C T Ly; F Jiang; C J Clendenin; K S Sigrist; R L Wollmann; E M McNally
Journal:  J Cell Biol       Date:  1998-09-07       Impact factor: 10.539

10.  Differential association of syntrophin pairs with the dystrophin complex.

Authors:  M F Peters; M E Adams; S C Froehner
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

View more
  27 in total

Review 1.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

2.  Changes in aging mouse neuromuscular junctions are explained by degeneration and regeneration of muscle fiber segments at the synapse.

Authors:  Yue Li; Young il Lee; Wesley J Thompson
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 3.  To build a synapse: signaling pathways in neuromuscular junction assembly.

Authors:  Haitao Wu; Wen C Xiong; Lin Mei
Journal:  Development       Date:  2010-04       Impact factor: 6.868

4.  Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy.

Authors:  Jessica E Poort; Mary B Rheuben; S Marc Breedlove; Cynthia L Jordan
Journal:  Hum Mol Genet       Date:  2016-08-04       Impact factor: 6.150

5.  Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy.

Authors:  Hiroshi Akima; Donovan Lott; Claudia Senesac; Jasjit Deol; Sean Germain; Ishu Arpan; Roxanna Bendixen; H Lee Sweeney; Glenn Walter; Krista Vandenborne
Journal:  Neuromuscul Disord       Date:  2011-07-31       Impact factor: 4.296

6.  The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins.

Authors:  Glen B Banks; Luke M Judge; James M Allen; Jeffrey S Chamberlain
Journal:  PLoS Genet       Date:  2010-05-20       Impact factor: 5.917

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

Review 8.  Eccentric exercise in aging and diseased skeletal muscle: good or bad?

Authors:  Richard M Lovering; Susan V Brooks
Journal:  J Appl Physiol (1985)       Date:  2013-03-07

9.  Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles.

Authors:  Stephen J P Pratt; Sameer B Shah; Christopher W Ward; Mario P Inacio; Joseph P Stains; Richard M Lovering
Journal:  J Physiol       Date:  2012-10-29       Impact factor: 5.182

10.  Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy.

Authors:  Jane T Seto; Niclas E Bengtsson; Jeffrey S Chamberlain
Journal:  Curr Pediatr Rep       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.